Navigation Links
China Pharma Holdings, Inc. to Present at Collins Stewart Fourth Annual Growth Conference in New York on July 8, 2008 at 2:00 p.m. EDT
Date:7/2/2008

NEW YORK and HAIKOU CITY, China, July 2 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. (''China Pharma'') (OTC Bulletin Board: CPHI) which develops, manufactures, and markets generic and branded bio- pharmaceutical products in China, today announced that the management will present at the Collins Stewart Fourth Annual Growth Conference on Tuesday, July 8th at 2:00 p.m. EDT. The conference is being held at the Mandarin Oriental Hotel in New York City, NY.

Mr. Xinhua Wu, China Pharma's CFO, and two senior managers Mr. Sam Hsing and Ms. Mary Wyatt will be representing China Pharma at the conference and will be available for one-on-one meetings with analysts and investors throughout the day. Mr. Hsing and Ms. Wyatt joined the Company recently. Mr. Hsing holds a Master degree in finance from University of Plymouth. Ms. Wyatt graduated from Manchester University with a BS in Molecular Biology and has studied and worked in China since 1999. They are both English-speaking members of senior management and will assist the Company in public financial and investor communications.

Management will discuss the Company's current product portfolio, development pipeline, research and development platform, recent financial highlights and its long-term growth strategy.

Participation is by invitation and registration is mandatory. For more information on the conference contact your Collins Stewart representative or visit http://www.collins-stewart.com .

About China Pharma Holdings, Inc.

China Pharma Holdings, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, i
'/>"/>

SOURCE China Pharma Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
5. China Technology Announces New Chief Financial Officer
6. China Medical Technologies Reports First Quarter Financial Results
7. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
8. China Technology Announces Entry to the Solar Energy Sector
9. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products
10. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
11. China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... , June 18, 2013 ... ) has announced the addition of the ... and Companies " to their offering. ... report briefly reviews basics of human genome ... applications. Current large and small sequencers are ...
(Date:6/18/2013)... Seattle, WA (PRWEB) June 18, 2013 Though ... May -- 11,000, according to the U.S. Bureau of Labor ... average increase of 24,000 per month. Most new health care ... while the hospital sector saw a loss of 6,000 jobs. ... Global outplacement consultancy firm Challenger, Gray & Christmas reported that ...
(Date:6/18/2013)... 2013 ActiGraph, a leading provider of ... global research community, announced today that Dr. Victor KR ... is the Scientific Director of the Physical Fitness Research ... of Medicine at Gama Filho University and the Chairman ... State Secretariat of Health of São Paulo State, Brazil. ...
(Date:6/17/2013)... 17, 2013  KaloBios Pharmaceuticals, Inc. (Nasdaq: ... R. Joseph as Chief Legal Officer.  Mr. Joseph ... experience and has worked in both public and private ... (Logo: http://photos.prnewswire.com/prnh/20130225/MM66380LOGO ) ... a general counsel and senior executive and his knowledge ...
Breaking Biology Technology:DNA Sequencing: Technologies, Markets and Companies - 2013 Report 2MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 2MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 3Dr. Victor KR Matsudo Joins ActiGraph Scientific Advisory Board 2KaloBios Appoints Donald R. Joseph as Chief Legal Officer 2KaloBios Appoints Donald R. Joseph as Chief Legal Officer 3KaloBios Appoints Donald R. Joseph as Chief Legal Officer 4
... May 9 Inverness Medical,Innovations (Amex: ... announced,acquisition of Matria Healthcare, Inc. was successfully ... business today, May 9, 2008. Matria,headquartered in ... particularly in the areas of women,s and,children,s ...
... of the 96 Core Curriculum Sessions Include Presentations from ... Committed to Magnetic Navigation Stereotaxis to Feature New Odyssey ... Generation Software Products in ... announced today that its participation at Heart Rhythm 2008 reflects,the broad ...
... 9 ,Takeda Pharmaceutical Company Limited, "Takeda", (TSE: 4502) ... today announced the,successful completion of Takeda,s cash tender ... acquire all outstanding shares,of Millennium common stock for ... for the tender offer expired at 12:00,midnight, New ...
Cached Biology Technology:Inverness Medical Innovations Completes Acquisition of Matria Healthcare, Inc. 2Stereotaxis' Market Leadership Highlighted at Heart Rhythm 2008 2Stereotaxis' Market Leadership Highlighted at Heart Rhythm 2008 3Stereotaxis' Market Leadership Highlighted at Heart Rhythm 2008 4Stereotaxis' Market Leadership Highlighted at Heart Rhythm 2008 5Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period 2Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period 3Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period 4Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period 5
(Date:6/18/2013)... The herbal extract of a yellow-flowered mountain plant long ... lifespan of fruit fly populations by an average of ... it,s how Rhodiola rosea , also ... attention of study leaders Mahtab Jafari and Sam Schriner. ... manner completely unrelated to dietary restriction and affects different ...
(Date:6/17/2013)... in the U.S. exposed to high levels of air pollution ... a child with autism as women who lived in areas ... School of Public Health (HSPH). It is the first large ... across the U.S. , "Our findings raise concerns since, depending ... our study lived in areas where risk of autism was ...
(Date:6/17/2013)... DETROIT On June 6, professors in Wayne ... only National Science Foundation-funded (NSF) Research Experience for ... undergraduates an opportunity to do cutting-edge research in ... , According to Alexey Petrov, Ph.D., professor of ... Arts, principal investigator and program director of the ...
Breaking Biology News(10 mins):Herbal extract boosts fruit fly lifespan by nearly 25 percent, UCI study finds 2Exposure to high pollution levels during pregnancy may increase risk of having child with autism 2Wayne State welcomes undergraduates from around the US for physics research experience 2
... According to the National Heart, Lung and Blood Institute, the ... five and 30 times a night. This lack of oxygen ... vascular disease, an abnormal heart rhythm, or even a fatal ... is exploring the changes in distinct brain regions that contribute ...
... Ind. -- The National Institute of Environmental Health ... researcher Joseph Shaw for a five-year study of ... and natural selection. The project reflects ... increasingly incorporating advances in molecular toxicology, computational sciences ...
... children,s long-term mental and behavioural development? This question will ... on child nutrition next 6th of October in York, ... Programme Nutrimenthe, entitled "Effect of diet on the mental ... by the European Commission through its 7th Framework Programme- ...
Cached Biology News:Researchers study sleep apnea and lack of oxygen 2Researcher awarded $2.27 million to study environmental effects on gene copy number 2Researcher awarded $2.27 million to study environmental effects on gene copy number 3Researcher awarded $2.27 million to study environmental effects on gene copy number 4Experts will meet to discuss how diet affects behavioral development of children 2
... Unconjugated Applications: ELISA: ... at an assay dependent dilution. WB: Use at ... concentration is determined using a whole extract of ... tested in other applications. Optimal dilutions/concentrations should ...
SHP-2 Antibody...
... (GLYT2). The antiserum has been tested on ... The staining pattern obtained with AB1773 corresponds ... hybridization with probes to GLYT2 mRNA and ... neurons. Preabsorption of the antiserum with the ...
... OA-Hy cis- 9-Octadecenoyl-N-hydroxylamide Oleoyl-N-hydroxylamide ... PACKAGED UNDER INERT GAS. A potent inhibitor ... manner (K i = 1.7 μM). ... in EtOH or DMSO. Unstable in solution, ...
Biology Products: